The basal ganglia and portal-systemic encephalopathy

Metabolic Brain Disease

Volumn 13, Issue 4, 1998, Pages 261-272

  Weissenborn, Karin ^a   Kolbe, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Ammonia; Basal ganglia function; Cognitive dysfunction; GABA; Glutamate; Hepatic encephalopathy; Portal systemic encephalopathy

Indexed keywords

4 AMINOBUTYRIC ACID; AMMONIA; GLUTAMIC ACID;

BASAL GANGLION; CLINICAL FEATURE; COGNITION; CONFERENCE PAPER; DIAGNOSTIC IMAGING; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

BASAL GANGLIA; BRAIN; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032421058     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020628607245     Document Type: Conference Paper

References (50)

1. Adams, R.D., Foley, JM. (1953). The neurological disorder associated with liver disease. In (H.H. Merritt and C.C. Hare eds.) Metabolic and Toxic Diseases of the Nervous System, Vol. 32, Williams and Wilkins, Baltimore, pp 198-237.
2. Basile, A.S., Skolnick, P., Jones, E.A. (1991). Benzodiazepine receptor ligands and hepatic encephalopathy: electrophysiological and neurochemical studies. In (F. Bengtsson, B. Jeppsson, T. Almdal, H. Vilstrup, eds.), Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange, CRC Press, Boca Raton, pp. 131-136.
3. Becker, G., Rohr, G., Gückel, F., Holm, E., Loose, R., Georgi, M. (1994). Follow up of hepatic encephalopathy by localized proton MR spectroscopy of the human brain. Proc. Soc. Magnetic Res., Vol I, 570.
4. Brooks, D.J. (1994). Functional imaging of movement disorders. In (C.D. Marsden and St. Fahn, eds.) Movement Disorders 3, Butterworth-Heinemann Ltd, Oxford, pp. 65-87
5. Brown, P. and Marsden, C.D. (1998). What do the basal ganglia do? Lancet 351:1801-1804.
6. Brunberg, J.A., Kanal, E., Hirsch, W. and Van Thiel, D.H. (1993). Chronic acquired hepatic failure: MR Imaging of the brain at 1.5 T. AJNR 12:909-914.
7. Butterworth, R.F. (1993). Portal-systemic encephalopathy: A disorder of neuron-astrocytic metabolic trafficking. Dev. Neurosci. 15: 313-319.
8. Greenamyre, J.T. (1993). Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease. J. Neural Transm. 91:255-269.
9. Hanner, J.S., Li, K.C.P. and Davis, G.L. (1988). Acquired hepatocerebral degeneration: MR similarity with Wilson Disease. J. Comp. Ass. Tomograph. 12:1076-1077.
10. Häussinger, D., Laubenberger, J., Vom Dahl, S., Ernst, T., Bayer, S., Langer, M. et al. (1994). Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterol. 107:1475-1480.
11. Hawkins, R.A., Jessy, J., Mans, A.M. and De Joseph, M.R. (1993). Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J. Neurochem. 60:1000-1006.
12. Hindfelt, B., Plum, F. and Duffy, T.E. (1977). Effect of acute ammonia intoxication on cerebral metabolism in rats with portocaval shunts. J. Clin. Invest. 59:386-396.
13. Huang, C.C., Chu, N.S., Lu, C.S., Chen, R.S. and Calne, D.B. (1998). Long-term progression in chronic manganism. Ten years of follow-up. Neurology 50:698-700.
14. Inoue, E., Hori, S., Narumi, Y., Fujita, M., Kuriyama, K., Kadota, T. and Kuroda, Ch. (1991). Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MRI images. Radiology 179:551-555
15. Kreis, R., Farrow, N. and Ross, B.D. (1991). Localized H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed. 4:109-116.
16. Kreis,R., Ross, B.D., Farrow, N.A. and Ackerman, Z. (1992). Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19-27
17. Krieger, S., Jau·, M., Jansen, O., Theilmann, L., Gei·ler, M. and Krieger, D. (1996). Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterol. 111:147-155.
18. Kucharzyk, W., Lenkinski, R.E., Kucharzyk, J. and Henkelman, R.M. (1990). The effect of phospholipid vesicles on the NMR relaxation of water: an explanation for the MR appearance of the neurohypophysis? AJNR 11:693-701.
19. Kulisevsky, J., Pujol, J., Balanzo, J., Junque, C., Deus, J., Capdevila, A. and Villanueva, C. (1992). Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatol. 16:1382-1388.
20. Kulisevsky, J., Pujol, J., Junque, C., Deus, J., Balanzo, J. and Capdevila, A. (1993). MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: Two different MRI patterns of clinical deterioration? Neurology 43:2570-2573.
21. Lien, Y.H., Michaelis, T., Moats, R.A. and Ross, B.D. (1994). Scyllo-inositol depletion in hepatic encephalopathy. Life Sci. 54:1507-1512.
22. Lockwood, A.H., Ginsberg, M.D., Rhoades, H.M. and Gutierrez, M.T. (1986). Cerebral glucose metabolism after portocaval shunting in the rat: patterns of metabolism and implications for the pathogenesis of hepatic encephalopathy. J. Clin. Invest. 78:86-95
23. Lockwood, A.H., Yap, E.W.H. and Wong, W.H. (1991a). Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab. 11:337-341.
24. Lockwood, A.H., Yap, E.W.H., Rhoades, H.M. and Wong, W.H. (1991b). Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J. Cereb. Blood Flow Metab. 11:331-336.
25. Lockwood, A.H., Murphy, B.W., Donnelly, K.Z., Mahl, T.C. and Perini, S. (1993). Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatol. 18:1061-1068.
26. Lovinger, D.M. and Tyler, E. (1996). Synaptic transmission and modulation in the neostriatum. In (R.J. Bradley, R.A. Harris and P. Jenner ,eds.), International Review of Neurobiology, Academic Press, London, pp.78-111
27. Mirowitz, S.A., Westrich, T.J. and Hirsch, J.D. (1991). Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radial. 181:117-120.
28. Mosher, T.J., Lacey, P.G., Barron, T.F., McNamara, K.P. and Devenyi, A.G. (1994). Increased signal intensity in the basal ganglia on T1-weighted MRI correlates with elevated erythrocyte manganese in patients with chronic liver disease. Proc. Soc. Magnetic Res., Vol.I, 8.
29. Mousseau, D.D., Perney, P., Pomier Layrargues, G. and Butterworth, R.F. (1993). Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci. Lett. 162:192-196.
30. Newland, M.C., Ceckler, T.L., Kordower, J.H. and Weiss, B. (1989). Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp. Neurol. 106:251-258.
31. Norenberg, M.D. (1977). A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab. Invest. 36:618-626.
32. Norenberg, M.D. and Bender, A.S. (1994). Astrocyte swelling in liver failure: Role of glutamine and benzodiazepines. Acta Neurochir. (Suppl) 60:24-27.
33. Norenberg, M.D. (1995). Hepatic encephalopathy. In (H. Kettenmann and B.R. Random, eds.) Neuraglia, Oxford University Press, Oxford, pp. 950-963.
34. Norenberg, M.D. (1998). Astroglial dysfunction in hepatic encephalopathy. Metab. Brain Dis., this volume.
35. Plum, F. and Hindfelt, B. (1976). The neurological complications of liver disease. In (P. Vinken and D.F. Bruyn, eds.) Handbook of Clinical Neurology, Vol. 27, Elsevier Science Publishers, Amsterdam, pp. 349-377
36. Pomier Layrargues, G., Spahr, L. and Butterworth, R.F. (1995). Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735-741.
37. Pugh, R.N.H., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C. and Will, R. (1973). Transection of the oesophagus for bleeding oesophageal varices. Brit. J. Surg. 60:646-649.
38. Pujol, A., Graus, F., Peri, J., Mercader, J.M. and Rimola, A. (1991). Hyperintensity in the globus pallidus on T1-weighted and inversion recovery MRI: a possible marker of advanced liver disease. Neurology 41:1526-1527.
39. Pujol, A., Pujol, J., Graus, F., Rimola, A., Peri, J., Mercader, J.M. et al. (1993). Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 43:65-69.
40. Pujol, J., Kulisevsky, M.D., Moreno, A., Deus, J., Alonso, J., Balanzo, J. et al. (1996). Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 47:1526-1530.
41. B in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res. 621:349-352.
42. Ross, B.D., Jacobson, S., Villamil, F., Korula, J., Kreis, R., Ernst, T. et al . (1994). Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities. Radiol.193:457-463.
43. Spahr, L., Butterworth, R.F., Fontaine, S., Bui, L., Therrien, G., Milette, P.C. et al. (1996). Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatol. 24:1116-1120.
44. Szerb, J.C. and Butterworth, R.F. (1991). Pre- and postsynaptic glutamatergic dysfunction in hepatic encephalopathy. In (F. Bengtsson, B. Jeppsson, T. Almdal and H. Vilstrup, eds) Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange, CRC Press, Boca Raton, pp. 183-195
45. Taylor-Robinson, S.D., Sargentoni, J., Marcus, C.D., Morgan, M.Y. and Bryant, D.J. (1994). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab. Brain Dis. 9:347-359.
46. Uchino, A., Miyoshi, T. and Ohno, M. (1989). Case report - MR imaging of chronic persistent hepatic encephalopathy. Radiat. Med. 7:257-260.
47. Warren, K.S. and Schenker, S. (1964). Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J. Lab. Clin. Med. 64:442-449.
48. Weissenborn, K., Ehrenheim, C., Hori, A., Kubicka, S. and Manns, M.P. (1995). Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab. Brain Dis. 10:219-231.
49. Weissenborn, K., Burchert, W., Bokemeyer, M., Ehrenheim, C., Kolbe, H., Manns, M.P. and Dengler, R. (1997). Regional differences of cerebral glucose metabolism in patients with liver cirrhosis depending on the grade of portosystemic encephalopathy (PSE). In (C. Record and H. Al-Mardini, eds.) Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, Medical Faculty University of Newcastle upon Tyne, Newcastle upon Tyne, pp. 359-363
50. Zeneroli, M.L., Cioni, G., Crisi, G., Vezzelli, C. and Ventura, E. (1991). Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: An MRI imaging study. Magnet. Res. Imaging 9:295-302.